Juvenile Myasthenia Gravis

Immunology·MeSH: Spinocerebellar ataxia 25

Prevalence

20.0 / 100K

Incidence

1.7 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Juvenile Myasthenia Gravis?

There are 2 clinical trials targeting Juvenile Myasthenia Gravis tracked by BioSniper.

What is the prevalence of Juvenile Myasthenia Gravis?

The estimated prevalence of Juvenile Myasthenia Gravis is approximately 20.0 per 100,000 population.

Deep-dive into Juvenile Myasthenia Gravis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Juvenile Myasthenia Gravis — Drugs in Development & Clinical Trials | BioSniper